Despite a robust cash position, Revolution Medicines' high burn rate and lofty valuation increase risk and sensitivity to ...

I-Mab (NASDAQ: IMAB) (the "Company”), a U.S.-based, global biotech company, focused on the development of precision ...

Called the Cancer in the UK Report 2025, the groundbreaking analysis reveals some fundamental facts about the average risk for developing cancer in the UK, and the probability of getting the all-clear ...

Monday, June 9, 2025. News & Perspective Drugs & Diseases CME & Education Video Decision Point Drugs & Diseases CME & Education Video Decision Point ...

The majority (n = 15) of non–navigation-based studies were centered on breast cancer populations. 6,16,17,19-21,24,26,37,38,40-42,45,46 One study combined education with emotional or psychological ...

Cancer death rates have fallen by more than a fifth in the last 50 years but cases are rising, according to a new analysis. A report from Cancer Research UK found people are now more likely to get ...

Immunotherapy Drugs Show Major Progress in Early-Stage Cancer Drugs that boost the body’s immune system to fight disease are showing promise in treating a variety of cancers in earlier stages, a ...

This report highlights that over 460 people die from cancer every single day in the UK, and too many cases are diagnosed at a late stage. “If we want to change that, we need bold action from the ...

Mortality in survivors of childhood cancer diagnosed with subsequent thyroid cancer: A report from the Childhood Cancer Survivor Study. Adjusted RRs and 95% confidence intervals for overall and ...

Journal Editorial Report: The week’s best and worst from Kim Strassel, Allysia Finley and Kyle Peterson. Which is more troubling—what we know about Iran’s nuclear program or what we don’t ...